PharmiWeb.com - Global Pharma News & Resources

Press Releases - 2020-04-22

Date Title Company
22-Apr-2020 New name: H.C. Starck Tantalum & Niobium becomes TANIOBIS TANIOBIS
22-Apr-2020 Targovax and Valo Therapeutics enter collaboration to develop RAS neoantigen coating of ONCOS viruses using PeptiCRAd technology Targovax ASA
22-Apr-2020 Care homes tragedy needs to be wake-up call says NHS Confederation NHS Confederation
22-Apr-2020 Eurofins Medical Device Testing commitment to support the safety and efficacy of devices used in the COVID-19 Crisis Response Eurofins Medical
22-Apr-2020 Blue Earth Diagnostics Continues to Expand Access to Axumin® (fluciclovine (18F)) with First Commercial Supply in Slovakia, Europe Blue Earth Diagnostics Ltd,
22-Apr-2020 Laboratory relocation firm offers free support for NHS Aport
22-Apr-2020 Viravaxx AG and the Medical University of Vienna have launched a project for an integrated platform for immune diagnosis and vaccination for COVID-19 Viravaxx AG
22-Apr-2020 Torx™ - a new web-based platform to keep chemists connected for faster quality candidate selection Torx Software
22-Apr-2020 South Wales business secures £226 million from HSBC UK to support essential industries during Covid-19 HSBC UK
22-Apr-2020 Sobi™ affiliate Florio GmbH, launches a new digital platform aiming to improve the lives of people with haemophilia Sobi
22-Apr-2020 Santhera’s Shareholders Approve all Board Proposals at Today’s Annual General Meeting Santhera Pharmaceuticals
22-Apr-2020 RHÖN-KLINIKUM Aktiengesellschaft: Reasoned Statements by the Board of Management and the Supervisory Board Regarding the Takeover Offer by Asklepios Kliniken GmbH & Co. KGaA RHÖN-KLINIKUM Aktiengesellschaft
22-Apr-2020 AskBio Acquires BrainVectis to Expand its Clinical Pipeline for Neurodegenerative Diseases AskBio
22-Apr-2020 Artificial Intelligence firm Biovista repositions four promising therapeutics against COVID-19 Biovista
22-Apr-2020 Artificial Intelligence firm Biovista repositions four promising therapeutics against COVID-19 Biovista
22-Apr-2020 BlueWillow Biologics® Announces Appointment of Chad Costley, MD, MBA, as Chief Medical Officer BlueWillow Biologics
22-Apr-2020 Arterys Arms Clinical AI Developers With a Web Platform for Medical Image Analysis to Accelerate Collaborative Research in the Fight Against COVID-19 Newswire
22-Apr-2020 BlueWillow Biologics® Announces Appointment of Chad Costley, MD, MBA, as Chief Medical Officer BlueWillow Biologics
22-Apr-2020 BlueWillow Biologics® Announces Appointment of Chad Costley, MD, MBA, as Chief Medical Officer BlueWillow Biologics
22-Apr-2020 Lonza to Host New Webinar – "3D Cell Culture Models for Respiratory Research" Lonza